News
-
-
-
-
-
-
-
-
PRESS RELEASE
Original-Research: Vidac Pharma Holding Plc (von Sphene Capital GmbH): Buy
Research analysis reveals the effectiveness of mitochondrial transplantation in increasing tumour cell sensitivity to chemotherapy, confirming Vidac Pharma's innovative approach. Buy recommendation maintained for Vidac Pharma -
PRESS RELEASE
5E Advanced Materials Announces Pricing of $8.31 Million Public Offering of Common Stock
5E Advanced Materials, Inc. announces pricing of underwritten public offering of common stock in the United States to raise approximately $8.31 million. Offering expected to close on August 25, 2025 -